<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoV, which enters the human cell 
 <italic>via</italic> the angiotensin-converting enzyme 2 receptor [
 <xref rid="C75" ref-type="bibr">75</xref>], usually presents with three phases [
 <xref rid="C76" ref-type="bibr">76</xref>]: 1) rapid viral replication with fever, cough and other nonspecific symptoms, disappearing in a few days; 2) high fever, hypoxaemia and progression to pneumonia-like symptoms, despite a progressive decline of viral replication; and 3) development of ARDS in around 20% of patients with mortality [
 <xref rid="C77" ref-type="bibr">77</xref>â€“
 <xref rid="C79" ref-type="bibr">79</xref>].
</p>
